Home >
Medicine Info >
Mycolon C Tablet
Loading interface...

Mycolon C Tablet

Manufactured byWATERLEY PHARMACEUTICALS PVT LTD
ContainsMebeverine (135 mg) + Chlordiazepoxide (5 mg)
Description
Mycolon C Tablet is used to relieve abdominal pain, spasm, flatulence, and other symptoms of irritable bowel syndrome (IBS), and also the excessive tension and anxiety associated with IBS. It is not recommended for use in patients less than 18 years of age.
QUICK LINKS:
Side effectsConcernsUsage

Side effects

Major & minor side effects for Mycolon C Tablet

  • Nausea and vomiting
  • Skin rash
  • Headache
  • Heartburn and indigestion
  • Constipation
  • Dizziness and Drowsiness
  • Change in mood
  • Unsteadiness
  • Loss of appetite
  • Shakiness in the legs, arms, hands, or feet
  • Decreased interest in sexual intercourse
  • Menstrual changes

Uses of Mycolon C Tablet

What is it prescribed for?

  • Irritable bowel syndrome
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The amount of time required for this medicine to show its action is not clinically established.
  • How long do the effects of this medicine last?
    The amount of time for which this medicine remains active in the body is not clinically established.
  • Is it safe to consume alcohol while taking this medicine?
    Consumption of alcohol is not recommended during treatment with this medicine due to the increased risk of severe adverse effects such as confusion, dizziness, nausea, vomiting, weakness, fainting, etc. It is advised that you do not perform any activities that require high mental alertness such as driving a vehicle or operating machinery if you consume alcohol while taking this medicine.
  • Is this a habit forming medicine?
    No habit-forming tendencies were reported.
  • Can this medicine be taken during pregnancy?
    This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.
  • Can this medicine be taken while breast-feeding?
    This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.

Allergy

This medicine is not recommended for use in patients with a known allergy to chlordiazepoxide, mebeverine, or any other inactive ingredients present along with the formulation.

Paralytic ileus

This medicine is not recommended for use in patients suffering from a paralytic ileus since it may worsen the patient's condition.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.
General warnings

Kidney Diseases

This medicine should be used with extreme caution in patients suffering from kidney diseases due to the increased risk of worsening of the patient's condition. Close monitoring of kidney function is necessary while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition of the patient.

Acute Porphyria

This medicine is not recommended for use in patients suffering from acute porphyria due to the increased risk of worsening of the patient's condition. Replacement with a suitable alternative should be considered based on the clinical condition of the patient.

Liver Diseases

This medicine should be used with extreme caution in patients with liver function impairment or active liver diseases due to the increased risk of severe adverse effects. Close monitoring of liver function is necessary while receiving this medicine. Report any symptoms such as nausea, fever, rashes, dark urine, etc. to the doctor on priority. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition.

Other medicines

Since this medicine may interact with other medicines and cause severe adverse effects, you are advised to report all your current medicines, including any herbs and supplements, to the doctor before beginning treatment with this medicine.

Withdrawal symptoms

Abrupt discontinuation of this medicine may increase the risk of adverse effects, especially if you have been using a high dose for a long duration. A gradual dose reduction is recommended to avoid these reactions. Do not stop the use of this medicine without consulting your doctor.

Driving or operating machinery

Use of this medicine may cause symptoms such as dizziness, blurred vision, confusion, drowsiness, etc. in some patients. It is advised that you do not perform any activities that require high mental alertness such as driving a vehicle or operating machinery if you experience any of these symptoms during treatment with this medicine.

Missed Dose

Take the missed dose as soon as you remember. If it is almost time for your next dose, skip the missed dose. Do not double your dose to make up for the missed one.

Overdose

Seek emergency medical treatment or contact the doctor in case of an overdose.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

N/A

Instructions

Consumption of alcohol is not recommended during treatment with this medicine due to the increased risk of severe adverse effects such as confusion, dizziness, nausea, vomiting, weakness, fainting, etc. It is advised that you do not perform any activities that require high mental alertness such as driving a vehicle or operating machinery if you consume alcohol while taking this medicine.
Interaction with Medicine

Cetirizine

Opioids

Antihypertensives

Orlistat

Mefloquine

Disease interactions

Seizure disorders

This medicine should be used with extreme caution in patients suffering from seizure disorder due to the increased risk of worsening of the patient's condition. Report any unusual symptoms to the doctor immediately. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition of the patient.

Depression

This medicine should be used with extreme caution in patients with a history of depression or other psychiatric disorders due to the increased risk of worsening of the patient's condition. Report any unusual symptoms to the doctor immediately. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition of the patient.
Food interactions
Information not available.
Lab interactions
Information not available.
This is not an exhaustive list of possible drug interactions. You should consult your doctor about all the possible interactions of the drugs you’re taking.
Take this medicine exactly advised by the doctor. Do not take in larger or smaller amounts than advised/prescribed. Consult the doctor if you experience any undesirable side effects. Ensure that the treatment course is completed. Do not stop the use of this medicine without consulting your doctor.
Miscelleneous

To be taken before food

To be taken as instructed by doctor

May cause sleepiness

How it works
Chlordiazepoxide works by stabilizing the brain cells and thus reduces the excitability of the brain cells. Mebeverine relaxes the muscles in the walls of the intestines and thereby relieves the symptoms such as spasms, pain, cramps, etc. associated with irritable bowel syndrome.
Legal Status

Approved

Unknown

Unknown

Unknown

Classification

Category

Anticholinergics/antispasmodics

Schedule

Schedule H1

DailyMed - Chlordiazepoxide hydrochloride capsule [Internet]. Dailymed.nlm.nih.gov. 2017 [cited 1 June 2017]. Available from:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=68c7d8a7-08b3-4a1a-acbd-09bbe67b8d4a

Mebeverine [Internet]. Pubchem.ncbi.nlm.nih.gov. 2018 [cited 31 July 2018]. Available from:

https://pubchem.ncbi.nlm.nih.gov/compound/mebeverine

Mebeverine - DrugBank [Internet]. Drugbank.ca. 2018 [cited 31 July 2018]. Available from:

https://www.drugbank.ca/drugs/DB12554

[Internet]. 2017 [cited 1 June 2017]. Available from:

https://www.medicines.org.uk/emc/medicine/10537
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 11 Jul 2019

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.